JVC Investment Partners is a venture capital firm that focuses on investing its own capital in individuals with exceptional vision, pioneering technologies, and significant promise, primarily within the healthcare, information technology, and life sciences sectors. Their strategy involves forming, investing in, and partnering with businesses across various development stages, with a strong emphasis on the people and their vision behind the ventures.
50% of their portfolio is in Healthcare. Average disclosed round size is $51.0M (across 3 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Magenta Medical | Growth | $105M | Jul 2024 |
 ImmPACT Bio USA, Inc. | Series A | $18M | Aug 2020 |
| Magenta Medical | Unknown | — | Jul 2019 |
| PPharma Two B Ltd. | Series C | $30M | Feb 2017 |
Top Co-Investors
OrbiMed2 shared
Novartis Venture Fund1 shared
Novo Holdings1 shared
Viking Global Investors1 shared
RA Capital Management1 shared
Alive Israel HealthTech Fund1 shared
aMoon1 shared
Last updated: 10 April 2026